Investors and major cannabis execs were in the same room April 17-18 at Benzinga’s Cannabis Capital Conference in Toronto. Here’s what six of the C-suite occupants had to say.
MariMed: ‘Power To Transform’
Cannabis has the “power to transform human and wellness,” said Robert Fireman, president and CEO of Marimed Inc (OTC: MRMD). One of the ways the medical cannabis company makes its mark is by offering a pure CBD product to treat children suffering from epilepsy, he said.
“We believe in the ‘Med’ in our name.”
Fireman said his company is the same size and boasts a similar capacity to some of the large well known multistate operators — but may be underappreciated by investors. To better emphasize its true size, Fireman said MariMed plans on restructuring its business.
A revamped image can help the company increase its pro forma revenue from $43.5 million in 2018 to a projected $330.1 million in 2021, the CEO said.
Part of the growth will come from a new subsidiary, MariMed Hemp, Fireman said.
Nextleaf: ‘Building Block’ Of Cannabis
Nextleaf Solutions Ltd (CNX: OILS) owns issued and pending patents for the process of producing cannabinoid distillate. The company is able to create odorless and tasteless THC or CBD, which makes it the “building block” for the cannabis industry, said CEO Paul Pedersen.
Nextleaf’s core purpose is to address one of the biggest headwinds for the cannabis industry: the oversupply of low-quality cannabis, the CEO said. The company understands that the secret to producing high-quality cannabis lies in the purifications and refinement steps, he said.
Nextleaf’s facilities are able to process 100,000 kg of dry cannabis and 300,000 liters of cannabis oil annually. The location was strategically selected, as 9 million square feet of cannabis greenhouse cultivation is located within a …